The federal Food and Drug Administration (FDA) has approved the first generic competitor to the EpiPen and EpiPen Jr., the auto-injector for the emergency treatment of life-threatening allergies. Mylan, the original manufacturers of the device, had been sharply criticized for raising the cost more than 400 percent over a decade, according to CNBC. The Israeli… Continue reading FDA Approves Generic Epi Pen